Old Web
English
Sign In
Acemap
>
authorDetail
>
Mattias Palmer
Mattias Palmer
AstraZeneca
Internal medicine
Heart rate
Almokalant
Medicine
Endocrinology
3
Papers
103
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Potassium and calcium current blocking properties of the novel antiarrhythmic agent H 345/52: implications for proarrhythmic potential
2001
Cardiovascular Research
Gregory J Amos
Christina Abrahamsson
Göran Duker
Luc M. Hondeghem
Mattias Palmer
Leif Carlsson
Show All
Source
Cite
Save
Citations (26)
Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart
1996
Journal of Cardiovascular Pharmacology
Tamás Fazekas
Leif Carlsson
Benjamin J. Scherlag
Philippe Mabo
Hervé Poty
Mattias Palmer
Eugene Patterson
Kenneth Berlin
G. L. Garrison
Ralph Lazzara
Show All
Source
Cite
Save
Citations (11)
Induction of rhythm abnormalities in the fetal rat heart. A tentative mechanism for the embryotoxic effect of the class III antiarrhythmic agent almokalant
1994
Cardiovascular Research
Christina Abrahamsson
Mattias Palmer
Bengt Ljung
Göran Duker
Catharina Bäärnhielm
Leif Carlsson
Bengt Danielsson
Show All
Source
Cite
Save
Citations (66)
1